Literature DB >> 24803611

Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.

Laura Magrini, Giulia Gagliano, Francesco Travaglino, Francesco Vetrone, Rossella Marino, Patrizia Cardelli, Gerardo Salerno, Salvatore Di Somma.   

Abstract

BACKGROUND: Procalcitonin (PCT) is currently the most studied infection biomarker and its blood levels seem to mirror the severity of illness and outcome. PCT is widely used together with other biomarkers, such as white blood cells (WBC) count and C reactive protein (CRP), in order to guide antibiotic therapy. This study aimed to verify the diagnostic and prognostic power of WBC, CRP and PCT in patients with suspected infection in emergency department (ED).
METHODS: A total of 513 patients presenting to the ED with signs/symptoms of local infections or sepsis were enrolled. APACHEII score and in-hospital death were recorded. Patients were subdivided into quartiles by age, and the biomarkers were measured at baseline. Receiver operating characteristics (ROC) curves for evaluating diagnostic and prognostic role of PCT, CRP and WBC were calculated for each variable alone and combined.
RESULTS: When compared each other for PCT, CRP, and WBC there was no significant difference between the four subgroups. A direct correlation between PCT and WBC was found in the II, III, and IV quartiles (the highest correlation, r=0.34, p<0.0003). PCT alone or when combined with WBC showed the best diagnostic and prognostic power at ROC analysis.
CONCLUSIONS: Our data demonstrate that WBC, but more CRP and PCT are reliable diagnostic and prognostic biomarkers, when considered in combination and with severity clinical score. PCT confirms its stronger usefulness as a diagnostic marker of sepsis. A multi-diagnostic tools approach is fundamental to perform a correct and rapid diagnosis of infection and sepsis in ED.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24803611     DOI: 10.1515/cclm-2014-0210

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  20 in total

Review 1.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

2.  Reduction in fecal microbiota diversity and short-chain fatty acid producers in Methicillin-resistant Staphylococcus aureus infected individuals as revealed by PacBio single molecule, real-time sequencing technology.

Authors:  J Zhao; L Nian; L Y Kwok; T Sun; J Zhao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-28       Impact factor: 3.267

3.  A risk score for early predicting bloodstream infections in febrile obstetric patients: a pilot study.

Authors:  Yaozong Zhang; Lan Li; Yunsheng Yan; Haifeng Qi; Jiali Qin; Li Ren; Ruoxuan Zhang
Journal:  Arch Gynecol Obstet       Date:  2021-10-03       Impact factor: 2.493

4.  Compartmentalization of acute phase reactants Interleukin-6, C-Reactive Protein and Procalcitonin as biomarkers of intra-amniotic infection and chorioamnionitis.

Authors:  Antonette T Dulay; Irina A Buhimschi; Guomao Zhao; Mert O Bahtiyar; Stephen F Thung; Michael Cackovic; Catalin S Buhimschi
Journal:  Cytokine       Date:  2015-05-06       Impact factor: 3.861

5.  Association of the immature platelet fraction with sepsis diagnosis and severity.

Authors:  Rodolfo Monteiro Enz Hubert; Melina Veiga Rodrigues; Bruna Dolci Andreguetto; Thiago M Santos; Maria de Fátima Pereira Gilberti; Vagner de Castro; Joyce M Annichino-Bizzacchi; Desanka Dragosavac; Marco Antonio Carvalho-Filho; Erich Vinicius De Paula
Journal:  Sci Rep       Date:  2015-01-26       Impact factor: 4.379

6.  Prognostic value of procalcitonin in respiratory tract infections across clinical settings.

Authors:  Alexander Kutz; Matthias Briel; Mirjam Christ-Crain; Daiana Stolz; Lila Bouadma; Michel Wolff; Kristina B Kristoffersen; Long Wei; Olaf Burkhardt; Tobias Welte; Stefan Schroeder; Vandack Nobre; Michael Tamm; Neera Bhatnagar; Heiner C Bucher; Charles-Edouard Luyt; Jean Chastre; Florence Tubach; Beat Mueller; Philipp Schuetz
Journal:  Crit Care       Date:  2015-03-06       Impact factor: 9.097

7.  Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.

Authors:  Anna Christina Rast; Alexander Kutz; Susan Felder; Lukas Faessler; Deborah Steiner; Svenja Laukemann; Sebastian Haubitz; Andreas Huber; Ulrich Buergi; Antoinette Conca; Barbara Reutlinger; Beat Mueller; Mario Bargetzi; Philipp Schuetz
Journal:  Dis Markers       Date:  2015-03-15       Impact factor: 3.434

Review 8.  Blood Procalcitonin Level as a Diagnostic Marker of Pediatric Bacterial Meningitis: A Systematic Review and Meta-Analysis.

Authors:  Heeyeon Kim; Yun-Ho Roh; Seo-Hee Yoon
Journal:  Diagnostics (Basel)       Date:  2021-05-08

9.  Presepsin in the Rapid Response System for Cancer Patients: A Retrospective Analysis.

Authors:  Min-Jung Lee; Won-Ho Han; June-Young Chun; Sun-Young Kim; Jee-Hee Kim
Journal:  J Clin Med       Date:  2021-05-16       Impact factor: 4.241

10.  Clinical Outcome Predictive Value of Procalcitonin in Patients Suspected with Infection in the Emergency Department.

Authors:  Pierre Leroux; Sébastien De Ruffi; Laurent Ramont; Marion Gornet; Guillaume Giordano Orsini; Xavier Losset; Lukshe Kanagaratnam; Stéphane Gennai
Journal:  Emerg Med Int       Date:  2021-06-10       Impact factor: 1.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.